Nivedita Findlay

Barramundi Ltd. engages in investment activities. Its objective is to give shareholders an opportunity to invest in companies through a single managed investment vehicle. The company was founded on September 8, 2006 and is headquartered in Auckland, New Zealand.

Marlin Global Ltd. is a closed-end investment fund/investment trust. It offers investors competitive returns and access to a diversified portfolio of investments through a single, tax efficient investment vehicle. The company investment objective is to achieve a high real rate of return, comprising both income and capital growth, within risk parameters acceptable to the directors. It provides access to a diversified portfolio of international growth stocks through a single tax-efficient investment vehicle. Marlin Global was founded on September 6, 2007 and is headquartered in Auckland, New Zealand.

Genesis Research & Development Corp. Ltd. operates as a development stage company. Previously, it was a technology investment company that builds a broad therapeutic development platform targeting immune disorders and cancer and a novel single stranded gene silencing technology using the RNAi mechanism. The company was founded by James Douglas Watson in 1994 and is headquartered in Auckland, New Zealand.